-

09:53:44 PM

BNIGF Stock News

BNIGF - Beroni Group Ltd.

06/01/22 8:30 AM

OTC : BNIGF

covid-19low float

Beroni Group’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced that it has received notification from its European Authorized Representative, CMC Medical Devices & Drugs SL, that its latest

RHEA-AI

very positive

03/31/22 8:25 AM

OTC : BNIGF

managementlow float

Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for

RHEA-AI

very positive

03/23/22 2:00 PM

OTC : BNIGF

conferenceslow float

Beroni Group to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for

RHEA-AI

neutral

01/31/22 8:30 AM

OTC : BNIGF

low float

Beroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, China

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for

RHEA-AI

neutral

11/18/21 8:30 AM

OTC : BNIGF

covid-19low float

Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and commercialization of therapies and products for

RHEA-AI

neutral

10/28/21 8:30 AM

OTC : BNIGF

low float

Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based biopharmaceutical enterprise, today announced that its article entitled “Crystal structures of the SARS-CoV-2 nucleocapsid protein C-terminal

RHEA-AI

neutral

09/09/21 8:30 AM

OTC : BNIGF

low float

Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has been approved by the

RHEA-AI

neutral

08/31/21 8:30 AM

OTC : BNIGF

clinical triallow float

Beroni Group Announced the Latest Clinical Study of its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method)

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced the latest clinical study of its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) demonstrated an overall sensitivity

RHEA-AI

neutral

08/18/21 8:30 AM

OTC : BNIGF

low float

Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise, announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has signed a drug

RHEA-AI

neutral

05/28/21 8:30 AM

OTC : BNIGF

low float

Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment

Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today announced that it has signed a Memorandum of Understanding with tella, Inc. (“tella”) to

RHEA-AI

positive